Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo

Regulatory T cells (T(reg)) are currently being tested in clinical trials as a potential therapy in cell and solid organ transplantation. The immunosuppressive drug rapamycin has been shown to preferentially promote T(reg) expansion. Here, we hypothesized that adjunctive rapamycin therapy might pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Hester, J, Schiopu, A, Nadig, S N, Wood, K J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440570/
https://www.ncbi.nlm.nih.gov/pubmed/22500984
http://dx.doi.org/10.1111/j.1600-6143.2012.04065.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440570/
https://www.ncbi.nlm.nih.gov/pubmed/22500984
http://dx.doi.org/10.1111/j.1600-6143.2012.04065.x

Ejemplares similares